TNXP

Tonix Pharmaceuticals Holding Corp

Stock NASDAQ – Stock Market Prices, News & Analysis

Tonix Pharmaceuticals Holding Corp is involved in the development of drugs to treat central nervous system disorders, including fibromyalgia and post-traumatic stress disorders.

$ 13.11
2.96 %

Tonix Pharmaceuticals Holding Corp

$ 13.11
2.96 %
TNXP

Tonix Pharmaceuticals Holding Corp is involved in the development of drugs to treat central nervous system disorders, including fibromyalgia and post-traumatic stress disorders.

Price history of Tonix Pharmaceuticals Holding Corp
Price history of Tonix Pharmaceuticals Holding Corp

Performance & Momentum

6 Months 29.44 %
1 Year 22.97 %
3 Years 99.86 %
5 Years 100.00 %

Strategic Analysis

Tonix Pharmaceuticals Holding Corp • 2026

Tonix Pharmaceuticals is a specialty biopharmaceutical company focused on complex medical indications, positioned at the intersection of pain, the central nervous system, immunology, and infectious diseases. Its appeal lies in a highly targeted clinical research strategy, but its business model remains that of a high-binary-risk development company, dependent on the progress of its programs and regulatory validation.

Strengths
  • Positioning in areas of significant and still underserved medical need, notably in pain and immunology
  • Diversification of research across several therapeutic areas, which can provide multiple sources of clinical optionality
  • Pure-play biotech profile that could react positively to trial progress, partnerships, or regulatory milestones
Weaknesses
  • High dependence on clinical and regulatory outcomes, with significant failure risk in each program
  • Very poor stock market history, signaling substantial value destruction and persistently weak investor confidence
Momentum

Momentum is weak and the underlying trend remains clearly bearish, reflecting the absence of a lasting stock market catalyst at this stage. For investors, this implies a speculative case rather than a quality growth stock: the market is waiting for concrete evidence of clinical or strategic progress before re-rating the shares.

Similar stocks to Tonix Pharmaceuticals Holding Corp

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone